In this study, mRNA levels of PPAR-γ were significantly reduced in type-2 diabetic rats whereas SIT treatment considerably upregulated (p < 0.05) the mRNA levels of PPAR-γ, which in turn proves the therapeutic effects of SIT (Figure 7). This evidence concerns the gene PPARG and type 2 diabetes mellitus.